There is, however, a potential problem with using pernicious anaemia as a model to predict the consequences of prolonged hypergastrinaemia in humans. Thus two studies have reported that the serum of some patients with pernicious anaemia contains an IgG antibody directed against the gastrin receptor which is capable of antagonising gastrin stimulated parietal cell secretion in vitro.'67 Such an antibody could conceivably exert a protective effect in patients -with pernicious anaemia by also blocking-the trophic action of gastrin on enterochromaffin-like cells. Therefore, despite high plasma concentrations, the biological activity of gastrin would be neutralised and hypergastrinaemia associated with pernicious anaemia would be an inappropriate model for comparison with drug induced hypergastrinaemia. The object of this study was to confirm or refute the presence of an antigastrin receptor antibody in the serum of patients with pernicious anaemia. Two systems were used to investigate inhibition of gastrin activity: an in vitro gastrin radioreceptor assay and an in vivo acid secretion model using the anaesthetised rat. 
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(0O5<p<0 7 by one way analysis of variance).
Injection of human IgG induced a slight increase in acid secretion in the rat but the effect was identical for control and pernicious anaemia samples. Integrated acid output in response to the second dose of gastrin is shown for individual IgG samples in Figure 3 . It is equally clear that neither intravenous (29 (1~0) ,umol H+/h) nor intragastric (30 (3 2) Ftmol H+/h) administration of IgG from patients with pernicious anaemia influenced gastrin stimulated acid output when compared with a corresponding control group (28 (2 4) ,umolh). Discussion A previous study reported the presence of an antigastrin receptor antibody in the serum of about 50% of patients with pernicious anaemia as detected by inhibition of gastrin stimulated aminopyrine uptake by isolated rodent parietal cells.'6 A second study has reported inhibition of basal acid secretion by bullfrog fundic mucosa and inhibition of gastrin stimulated carbonic anhydrase activity assessed in a cytochemical assay.'7 One further report has described the presence of an antibody against the gastrin receptor in a proportion of patients with pernicious anaemia as determined from binding studies in an enriched parietal cell preparation from rat gastric mucosa. '9 The experiments reported in the present paper did not confirm the presence of an antigastrin receptor antibody in the IgG fraction of serum from any of the 
